European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET)

The aim of the present guidance paper is to update the previous ENETS guidelines on well differentiated appendiceal neuroendocrine tumours (NET), providing practical guidance for the diagnosis and management of appendiceal NET (aNET); poorly differentiated neoplasms are dealt with in a separate guidance paper. This paper is structured on a question‐answer format in order to also address controversial issues and areas where uncertainty regarding the management and follow‐up of aNET exists. All recommendations are offered on the basis of the best available evidence, along with the authors' experiences in managing these neoplasms. Each recommendation for treatment will provide a level of evidence and grade of recommendation as per the GRADE system (adapted in Infectious Disease Society of United States Public Health Service grading system).

[1]  M. Zwahlen,et al.  Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study. , 2023, The Lancet. Oncology.

[2]  Y. Shibahara,et al.  Appendiceal Well-Differentiated Neuroendocrine Tumors: A Single-Center Experience and New Insights into the Effective Use of Immunohistochemistry , 2022, International journal of surgical pathology.

[3]  J. Capdevila,et al.  Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy , 2022, World journal of gastroenterology.

[4]  T. Pawlik,et al.  Surgical Treatment of Neuroendocrine Tumors of the Terminal Ileum or Cecum: Ileocecectomy Versus Right Hemicolectomy , 2022, Journal of Gastrointestinal Surgery.

[5]  M. V. van Velthuysen,et al.  ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology , 2022, Journal of neuroendocrinology.

[6]  C. Verslype,et al.  Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015. , 2021, Acta gastro-enterologica Belgica.

[7]  M. Falconi,et al.  Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy , 2021, Annals of surgery.

[8]  P. Janik,et al.  Radical surgical treatment of neuroendocrine tumors of the appendix in children – a Polish multicenter study , 2021, Archives of medical science : AMS.

[9]  A. Kjær,et al.  Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of Excellence. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  D. Cuthbertson,et al.  The impact of lymph node metastases and right hemicolectomy on outcomes in appendiceal neuroendocrine tumours (aNETs). , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  D. Bailey,et al.  Routine Early 68Ga-DOTATATE Positron Emission Tomography Has Low Yield After Resection of Appendiceal Neuroendocrine Neoplasms , 2020, Pancreas.

[12]  M. Weickert,et al.  The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN , 2020, Endocrine.

[13]  E. Baudin,et al.  Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[14]  G. Rossi,et al.  Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study. , 2020, Annals of surgery.

[15]  A. Pierro,et al.  Management of pediatric appendiceal carcinoid: a single institution experience from 5000 appendectomies , 2019, Pediatric Surgery International.

[16]  G. Kaltsas,et al.  The risk of lymph node metastases and their impact on survival in patients with appendiceal neuroendocrine neoplasms: a systematic review and meta-analysis of adult and paediatric patients , 2019, Endocrine.

[17]  A. Tabarin,et al.  Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE). , 2019, Annals of surgery.

[18]  V. Ambrosini,et al.  Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis , 2019, Endocrine.

[19]  M. Galanopoulos,et al.  Challenging the Current Risk Factors of Appendiceal Neuroendocrine Neoplasms: Can They Accurately Predict Local Lymph Nodal Invasion? Results from a Large Case Series , 2019, Neuroendocrinology.

[20]  L. Hofland,et al.  Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers. , 2019, Endocrine-related cancer.

[21]  S. Partelli,et al.  Unmet Needs in Appendiceal Neuroendocrine Neoplasms , 2018, Neuroendocrinology.

[22]  I. Jeffrey,et al.  Systematic review and meta‐analysis of appendiceal carcinoid tumors in children , 2018, Pediatric blood & cancer.

[23]  C. Conrad,et al.  Regional lymph node involvement and outcomes in appendiceal neuroendocrine tumors: a SEER database analysis , 2017, Oncotarget.

[24]  A. Darzi,et al.  Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More , 2017, Neuroendocrinology.

[25]  S. Ikeda,et al.  The mutational landscape of gastrointestinal malignancies as reflected by circulating tumor DNA. , 2017 .

[26]  R. Jensen,et al.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification , 2017, Neuroendocrinology.

[27]  P. Kienle,et al.  Long‐term functional outcome of colonic resections: how much does faecal impairment influence quality of life? , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[28]  D. Orbach,et al.  Surgical Management of Neuroendocrine Tumors of the Appendix in Children and Adolescents: A Retrospective French Multicenter Study of 114 Cases , 2016, Pediatric blood & cancer.

[29]  E. Krenning,et al.  ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas) , 2016, Neuroendocrinology.

[30]  I. Leuschner,et al.  Neuroendocrine tumors of the appendix in children and adolescents , 2013, Pediatric blood & cancer.

[31]  S. Grozinsky-Glasberg,et al.  Current Size Criteria for the Management of Neuroendocrine Tumors of the Appendix: Are They Valid? Clinical Experience and Review of the Literature , 2012, Neuroendocrinology.

[32]  J. Mullen,et al.  Carcinoid tumors of the appendix: A population‐based study , 2011, Journal of surgical oncology.

[33]  J. Griniatsos,et al.  Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria , 2011, Journal of endocrinological investigation.

[34]  Manal M. Hassan,et al.  The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum , 2010, Pancreas.

[35]  G. Kazemier,et al.  Carcinoid Tumour of the Appendix: An Analysis of 1,485 Consecutive Emergency Appendectomies , 2008, Journal of Gastrointestinal Surgery.

[36]  G. Guyatt,et al.  What is “quality of evidence” and why is it important to clinicians? , 2008, BMJ : British Medical Journal.

[37]  A. Scarpa,et al.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system , 2006, Virchows Archiv : an international journal of pathology.

[38]  D. Breen,et al.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) , 2005, Gut.

[39]  D. Nagorney,et al.  Carcinoid tumor of the appendix: treatment and prognosis. , 1987, The New England journal of medicine.

[40]  A. Colao,et al.  Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. , 2018, Endocrine-related cancer.

[41]  A. Grossman,et al.  Appendiceal neuroendocrine neoplasms: diagnosis and management. , 2016, Endocrine-related cancer.

[42]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.